Loading…
Please register to continue your trial period!
meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.
Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.
Start your free trial and transform your understanding of the gut microbiota today!
The trial was a Phase III study focusing on confirming the effectiveness and monitoring adverse reactions in a larger patient group. It was designed to include participants across a wide age range, from adolescents (13 to 15 years), adults (16 to 65 years), to the elderly (>65 to <85 years).
Despite the initial promise, the unfavorable outcome led to the discontinuation of Pimodivir's development for influenza treatment.…